{"id":"https://openalex.org/W2018644412","doi":"https://doi.org/10.1111/febs.12180","title":"Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma","display_name":"Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma","alternate_titles":[],"publication_year":2013,"publication_date":"2013-03-04","ids":{"openalex":"https://openalex.org/W2018644412","doi":"https://doi.org/10.1111/febs.12180","mag":"2018644412","pmid":"https://pubmed.ncbi.nlm.nih.gov/23419151"},"language":"en","primary_location":{"id":"doi:10.1111/febs.12180","doi":"https://doi.org/10.1111/febs.12180","is_oa":false,"landing_page_url":"https://doi.org/10.1111/febs.12180","pdf_url":null,"source":{"id":"https://openalex.org/S37672443","display_name":"FEBS Journal","issn_l":"1742-464X","issn":["1742-464X","1742-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FEBS Journal","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2018644412"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008908090","display_name":"Rogier M. Reijmers","orcid":"https://orcid.org/0000-0001-7471-7715","observed_orcids":["https://orcid.org/0000-0001-7471-7715"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rogier M. Reijmers","raw_affiliation_strings":["Department of Pathology Academic Medical Center Amsterdam The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology Academic Medical Center Amsterdam The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035092788","display_name":"Marcel Spaargaren","orcid":"https://orcid.org/0000-0002-3135-5109","observed_orcids":["https://orcid.org/0000-0002-3135-5109"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcel Spaargaren","raw_affiliation_strings":["Department of Pathology Academic Medical Center Amsterdam The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology Academic Medical Center Amsterdam The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5032324734","display_name":"Steven T. Pals","orcid":"https://orcid.org/0000-0002-1419-0939","observed_orcids":["https://orcid.org/0000-0002-1419-0939"]},"institutions":[{"id":"https://openalex.org/I2802928900","display_name":"Amsterdam UMC Location University of Amsterdam","ror":"https://ror.org/03t4gr691","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I2802928900","https://openalex.org/I4210151833"]}],"countries":["NL"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Steven T. Pals","raw_affiliation_strings":["Department of Pathology Academic Medical Center Amsterdam The Netherlands"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology Academic Medical Center Amsterdam The Netherlands","institution_ids":["https://openalex.org/I2802928900"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5032324734"],"corresponding_institution_ids":["https://openalex.org/I2802928900"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":0.5468,"has_fulltext":false,"cited_by_count":67,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.45919779,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":99},"biblio":{"volume":"280","issue":"10","first_page":"2180","last_page":"2193"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11131","display_name":"Proteoglycans and glycosaminoglycans research","score":0.9804999828338623,"subfield":{"id":"https://openalex.org/subfields/1307","display_name":"Cell Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.01730000041425228,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/heparan-sulfate-proteoglycans","display_name":"heparan sulfate proteoglycans","score":0.9990000128746033},{"id":"https://openalex.org/keywords/b-cell-development","display_name":"B cell development","score":0.8640000224113464},{"id":"https://openalex.org/keywords/multiple-myeloma","display_name":"multiple myeloma","score":0.9829999804496765},{"id":"https://openalex.org/keywords/syndecan-1","display_name":"syndecan-1","score":0.9929999709129333},{"id":"https://openalex.org/keywords/b-cell-maturation","display_name":"B cell maturation","score":0.6539999842643738},{"id":"https://openalex.org/keywords/plasma-cell-survival","display_name":"plasma cell survival","score":0.7480000257492065},{"id":"https://openalex.org/keywords/bone-marrow-microenvironment","display_name":"bone marrow microenvironment","score":0.9679999947547913},{"id":"https://openalex.org/keywords/heparan-sulfate-biosynthesis","display_name":"heparan sulfate biosynthesis","score":0.6919999718666077},{"id":"https://openalex.org/keywords/bortezomib","display_name":"bortezomib","score":0.7789999842643738},{"id":"https://openalex.org/keywords/lenalidomide","display_name":"lenalidomide","score":1.0},{"id":"https://openalex.org/keywords/dexamethasone","display_name":"dexamethasone","score":0.9829999804496765},{"id":"https://openalex.org/keywords/drug-sensitivity","display_name":"drug sensitivity","score":0.40400001406669617}],"concepts":[{"id":"https://openalex.org/C2778041096","wikidata":"https://www.wikidata.org/wiki/Q424668","display_name":"Heparan sulfate","level":3,"score":0.7802062034606934},{"id":"https://openalex.org/C65001120","wikidata":"https://www.wikidata.org/wiki/Q14912913","display_name":"Syndecan 1","level":3,"score":0.7259543538093567},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.5486968755722046},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.475620299577713},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.46563899517059326},{"id":"https://openalex.org/C22731427","wikidata":"https://www.wikidata.org/wiki/Q2071346","display_name":"Perlecan","level":4,"score":0.4595351219177246},{"id":"https://openalex.org/C2776396001","wikidata":"https://www.wikidata.org/wiki/Q250694","display_name":"Plasma cell","level":3,"score":0.4581294655799866},{"id":"https://openalex.org/C2777478702","wikidata":"https://www.wikidata.org/wiki/Q419319","display_name":"Bortezomib","level":3,"score":0.45759233832359314},{"id":"https://openalex.org/C145103041","wikidata":"https://www.wikidata.org/wiki/Q1151519","display_name":"Embryonic stem cell","level":3,"score":0.4512743353843689},{"id":"https://openalex.org/C2778453870","wikidata":"https://www.wikidata.org/wiki/Q188930","display_name":"B cell","level":3,"score":0.43492695689201355},{"id":"https://openalex.org/C148738053","wikidata":"https://www.wikidata.org/wiki/Q210861","display_name":"Cellular differentiation","level":3,"score":0.4286154508590698},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.40428808331489563},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4014856815338135},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.36787527799606323},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.31295573711395264},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.293526291847229},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.24299263954162598},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1693282127380371},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.08724069595336914}],"mesh":[{"descriptor_ui":"D000099058","descriptor_name":"Exostosin 1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D001402","descriptor_name":"B-Lymphocytes","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D002454","descriptor_name":"Cell Differentiation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003907","descriptor_name":"Dexamethasone","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D004318","descriptor_name":"Doxycycline","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D009101","descriptor_name":"Multiple Myeloma","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D015972","descriptor_name":"Gene Expression Regulation, Neoplastic","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017351","descriptor_name":"N-Acetylglucosaminyltransferases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D017351","descriptor_name":"N-Acetylglucosaminyltransferases","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019812","descriptor_name":"Heparan Sulfate Proteoglycans","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D053668","descriptor_name":"Syndecan-1","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D054377","descriptor_name":"Chemokine CXCL12","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D059016","descriptor_name":"Tumor Microenvironment","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1111/febs.12180","doi":"https://doi.org/10.1111/febs.12180","is_oa":false,"landing_page_url":"https://doi.org/10.1111/febs.12180","pdf_url":null,"source":{"id":"https://openalex.org/S37672443","display_name":"FEBS Journal","issn_l":"1742-464X","issn":["1742-464X","1742-4658"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FEBS Journal","raw_type":"journal-article"},{"id":"pmid:23419151","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23419151","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The FEBS journal","raw_type":"Journal Article"},{"id":"pmh:oai:pure.amsterdamumc.nl:openaire_cris_publications/9512df05-f5ed-4806-bda1-2113b662e15b","doi":null,"is_oa":false,"landing_page_url":"https://pure.amsterdamumc.nl/en/publications/9512df05-f5ed-4806-bda1-2113b662e15b","pdf_url":null,"source":{"id":"https://openalex.org/S7407055222","display_name":"Pure Amsterdam UMC","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Reijmers, R M, Spaargaren, M & Pals, S T 2013, 'Heparan sulfate proteoglycans in the control of B cell development and the pathogenesis of multiple myeloma', FEBS journal, vol. 280, no. 10, pp. 2180-2193. https://doi.org/10.1111/febs.12180","raw_type":"info:eu-repo/semantics/review"},{"id":"pmh:amcpub:oai:pure.amc.nl:publications/0484b1a6-b160-455d-be30-45e1e879ad10","doi":null,"is_oa":false,"landing_page_url":"https://pure.amc.nl/en/publications/heparan-sulfate-proteoglycans-in-the-control-of-b-cell-development-and-the-pathogenesis-of-multiple-myeloma(0484b1a6-b160-455d-be30-45e1e879ad10).html","pdf_url":null,"source":{"id":"https://openalex.org/S4306401843","display_name":"Data Archiving and Networked Services (DANS)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1322597698","host_organization_name":"Royal Netherlands Academy of Arts and Sciences","host_organization_lineage":["https://openalex.org/I1322597698"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"FEBS journal, 280(10), 2180 - 2193. Wiley-Blackwell","raw_type":"info:eu-repo/semantics/other"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8560000061988831}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320322777","display_name":"KWF Kankerbestrijding","ror":"https://ror.org/0368jnd28"}],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":119,"referenced_works":["https://openalex.org/W44384258","https://openalex.org/W1520757652","https://openalex.org/W1526312778","https://openalex.org/W1571736940","https://openalex.org/W1574887471","https://openalex.org/W1598444116","https://openalex.org/W1608390571","https://openalex.org/W1626251921","https://openalex.org/W1637367454","https://openalex.org/W1855999912","https://openalex.org/W1965540093","https://openalex.org/W1970371303","https://openalex.org/W1971351550","https://openalex.org/W1971540677","https://openalex.org/W1974432307","https://openalex.org/W1974478155","https://openalex.org/W1976073214","https://openalex.org/W1977877980","https://openalex.org/W1980248785","https://openalex.org/W1982312174","https://openalex.org/W1983381655","https://openalex.org/W1984608133","https://openalex.org/W1990081266","https://openalex.org/W1991787503","https://openalex.org/W1996795546","https://openalex.org/W2005284010","https://openalex.org/W2007744512","https://openalex.org/W2009169267","https://openalex.org/W2009795125","https://openalex.org/W2009962397","https://openalex.org/W2010552629","https://openalex.org/W2010683995","https://openalex.org/W2015714938","https://openalex.org/W2017328208","https://openalex.org/W2018890642","https://openalex.org/W2026549568","https://openalex.org/W2027795299","https://openalex.org/W2028101194","https://openalex.org/W2031143008","https://openalex.org/W2037974914","https://openalex.org/W2040889135","https://openalex.org/W2041091423","https://openalex.org/W2041768758","https://openalex.org/W2043484559","https://openalex.org/W2047059447","https://openalex.org/W2047649254","https://openalex.org/W2053206569","https://openalex.org/W2067314001","https://openalex.org/W2068849880","https://openalex.org/W2070135451","https://openalex.org/W2070741299","https://openalex.org/W2071177355","https://openalex.org/W2075422129","https://openalex.org/W2075630737","https://openalex.org/W2075657769","https://openalex.org/W2080075942","https://openalex.org/W2080170092","https://openalex.org/W2084253807","https://openalex.org/W2085265892","https://openalex.org/W2085524191","https://openalex.org/W2085817610","https://openalex.org/W2086218235","https://openalex.org/W2086591577","https://openalex.org/W2087082206","https://openalex.org/W2089222579","https://openalex.org/W2089478119","https://openalex.org/W2092998387","https://openalex.org/W2095020121","https://openalex.org/W2095255742","https://openalex.org/W2095373191","https://openalex.org/W2096629111","https://openalex.org/W2101016269","https://openalex.org/W2102408296","https://openalex.org/W2104124057","https://openalex.org/W2110168092","https://openalex.org/W2111065217","https://openalex.org/W2111912987","https://openalex.org/W2113266466","https://openalex.org/W2114568695","https://openalex.org/W2120903363","https://openalex.org/W2121179180","https://openalex.org/W2121722225","https://openalex.org/W2122306511","https://openalex.org/W2122680899","https://openalex.org/W2124119706","https://openalex.org/W2125347681","https://openalex.org/W2125947059","https://openalex.org/W2126052429","https://openalex.org/W2126120941","https://openalex.org/W2128395962","https://openalex.org/W2132079001","https://openalex.org/W2132120901","https://openalex.org/W2133459531","https://openalex.org/W2134125940","https://openalex.org/W2135640361","https://openalex.org/W2140754506","https://openalex.org/W2141149908","https://openalex.org/W2141843510","https://openalex.org/W2144430905","https://openalex.org/W2145345130","https://openalex.org/W2146074826","https://openalex.org/W2150436360","https://openalex.org/W2150561062","https://openalex.org/W2151733176","https://openalex.org/W2152417566","https://openalex.org/W2155988482","https://openalex.org/W2156014566","https://openalex.org/W2158862842","https://openalex.org/W2161953839","https://openalex.org/W2162312857","https://openalex.org/W2164405645","https://openalex.org/W2166030007","https://openalex.org/W2265877479","https://openalex.org/W2281648910","https://openalex.org/W2405947168","https://openalex.org/W3195431600","https://openalex.org/W4210271223","https://openalex.org/W4211135634","https://openalex.org/W4238813159"],"related_works":["https://openalex.org/W3122153833","https://openalex.org/W4236123668","https://openalex.org/W2265877479","https://openalex.org/W4247964396","https://openalex.org/W2114568695","https://openalex.org/W2532275089","https://openalex.org/W2080170092","https://openalex.org/W2110168092","https://openalex.org/W2888294728"],"abstract_inverted_index":{"Heparan":[0],"sulfate":[1,36],"proteoglycans":[2],"(HSPGs)":[3],"have":[4],"essential":[5,124],"functions":[6,112],"during":[7],"embryonic":[8],"development":[9,52],"and":[10,53,65,79,105,132],"throughout":[11],"postnatal":[12],"life.":[13],"To":[14],"exert":[15],"these":[16,164],"functions,":[17],"they":[18],"undergo":[19],"a":[20,45,97,114,171],"series":[21],"of":[22,48,56,67,75,82,128,139],"processing":[23],"reactions":[24],"by":[25,72],"heparan-sulfate-modifying":[26],"enzymes":[27],"(HSMEs),":[28],"which":[29,83],"endows":[30],"them":[31],"with":[32],"highly":[33],"modified":[34],"heparan":[35],"(HS)":[37],"domains":[38],"that":[39],"provide":[40],"specific":[41],"docking":[42],"sites":[43],"for":[44,99,117,125,174],"large":[46],"number":[47],"bioactive":[49],"molecules.":[50],"The":[51],"antigen-dependent":[54],"differentiation":[55,104],"normal":[57,100],"B":[58,101],"lymphocytes,":[59],"as":[60,62,113],"well":[61],"the":[63,109,120,126,167],"growth":[64,76],"progression":[66],"B-lineage":[68],"malignancies,":[69],"are":[70],"orchestrated":[71],"an":[73],"array":[74],"factors,":[77],"cytokines":[78],"chemokines":[80],"many":[81],"display":[84],"HS":[85,142,168],"binding.":[86],"As":[87],"discussed":[88],"in":[89,154],"this":[90],"review,":[91],"tightly":[92],"regulated":[93],"HSPG":[94,110],"expression":[95],"is":[96],"requirement":[98],"cell":[102],"maturation,":[103],"function.":[106],"In":[107],"addition,":[108],"syndecan-1":[111],"versatile":[115],"co-receptor":[116],"signals":[118],"from":[119],"bone":[121],"marrow":[122],"microenvironment,":[123],"survival":[127],"long-lived":[129],"plasma":[130,136],"cells":[131,146],"multiple":[133],"myeloma":[134],"(MM)":[135],"cells.":[137],"Targeting":[138],"HSMEs":[140],"or":[141,160],"chains":[143],"on":[144],"MM":[145,155,175],"increases":[147],"their":[148],"sensitivity":[149],"to":[150],"drugs":[151],"currently":[152],"used":[153],"treatment,":[156],"including":[157],"bortezomib,":[158],"lenalidomide":[159],"dexamethasone.":[161],"Taken":[162],"together,":[163],"findings":[165],"render":[166],"biosynthetic":[169],"machinery":[170],"promising":[172],"target":[173],"treatment.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2018644412","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":11},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":6},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":7},{"year":2013,"cited_by_count":5}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
